Filing Details

Accession Number:
0001437749-20-019524
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-09 21:28:27
Reporting Period:
2020-09-04
Accepted Time:
2020-09-09 21:28:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029125 Sun Biopharma Inc. SNBP Pharmaceutical Preparations (2834) 870543922
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1652797 W. Paul Schaffer 712 Vista Blvd #305
Waconia MN 55387
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-04 24,775 $2.51 159,195 No 4 P Direct
Common Stock Acquisiton 2020-09-08 225 $2.55 159,420 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 30,665 Indirect By Paul W. Schaffer Trust
Footnotes
  1. Reflects the weighted average price of 24,775 shares of common stock of Sun BioPharma, Inc. purchased by the reporting person in multiple transactions on September 4, 2020 with purchase prices ranging from $2.4298 to $2.55 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.